Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRI-based Assessment of Tumor Hypoxia in Brain Metastases and Head/Neck Cancer
NCT05996432Phase 1Recruiting
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Start
- May 2023
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial (2 arms), sponsored by Vanderbilt-Ingram Cancer Center. Primary endpoint: Validation of non-invasive, MRI-based markers of tumor hypoxia at 1.5 years. Started May 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05996432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05996432.